Stericycle, Inc. (NASDAQ:SRCL – Get Rating) has been given an average recommendation of “Hold” by the six analysts that are presently covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $58.67.
Separately, StockNews.com upgraded Stericycle from a “hold” rating to a “buy” rating in a report on Friday.
Institutional Trading of Stericycle
Large investors have recently bought and sold shares of the company. Eagle Asset Management Inc. boosted its position in Stericycle by 4.8% during the 1st quarter. Eagle Asset Management Inc. now owns 27,539 shares of the business services provider’s stock valued at $1,622,000 after acquiring an additional 1,252 shares in the last quarter. Cerity Partners LLC boosted its position in shares of Stericycle by 66.3% in the 1st quarter. Cerity Partners LLC now owns 23,533 shares of the business services provider’s stock worth $1,387,000 after purchasing an additional 9,380 shares in the last quarter. Van ECK Associates Corp boosted its position in shares of Stericycle by 11.5% in the 1st quarter. Van ECK Associates Corp now owns 44,818 shares of the business services provider’s stock worth $2,641,000 after purchasing an additional 4,607 shares in the last quarter. Truist Financial Corp boosted its position in shares of Stericycle by 6.8% in the 1st quarter. Truist Financial Corp now owns 20,615 shares of the business services provider’s stock worth $1,215,000 after purchasing an additional 1,314 shares in the last quarter. Finally, Raymond James Trust N.A. boosted its position in shares of Stericycle by 7.2% in the 2nd quarter. Raymond James Trust N.A. now owns 20,243 shares of the business services provider’s stock worth $888,000 after purchasing an additional 1,356 shares in the last quarter. 98.05% of the stock is owned by institutional investors.
Stericycle Price Performance
NASDAQ SRCL traded down $1.18 during trading hours on Friday, reaching $42.43. 447,168 shares of the stock traded hands, compared to its average volume of 441,665. The stock has a 50 day simple moving average of $49.10 and a two-hundred day simple moving average of $49.12. Stericycle has a 1 year low of $40.35 and a 1 year high of $70.91. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.96 and a quick ratio of 0.96. The company has a market cap of $3.91 billion, a price-to-earnings ratio of -44.66, a price-to-earnings-growth ratio of 2.76 and a beta of 1.27.
Stericycle (NASDAQ:SRCL – Get Rating) last released its quarterly earnings data on Friday, August 5th. The business services provider reported $0.48 EPS for the quarter, topping the consensus estimate of $0.43 by $0.05. The firm had revenue of $679.80 million for the quarter, compared to the consensus estimate of $678.27 million. Stericycle had a positive return on equity of 6.22% and a negative net margin of 3.28%. The company’s quarterly revenue was up 1.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.67 earnings per share. On average, analysts predict that Stericycle will post 2.01 EPS for the current fiscal year.
About Stericycle
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including sharps disposable and management solutions; pharmaceutical waste services; hazardous waste disposal; maritime waste services, such as seaport and airport waste; and compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Stericycle, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Stericycle wasn’t on the list.
While Stericycle currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
Read More: Stericycle, Inc. (NASDAQ:SRCL) Receives Consensus Rating of “Hold” from Brokerages